scholarly journals Mechanistic insights into the protective roles of polyphosphate against amyloid cytotoxicity

2019 ◽  
Vol 2 (5) ◽  
pp. e201900486 ◽  
Author(s):  
Justine Lempart ◽  
Eric Tse ◽  
James A Lauer ◽  
Magdalena I Ivanova ◽  
Alexandra Sutter ◽  
...  
Keyword(s):  
Extracellular Space ◽  
Therapeutic Strategy ◽  
Neuronal Cells ◽  
Lewy Bodies ◽  
Fibril Formation ◽  
Amyloid Protein ◽  
Rate Limiting Step ◽  
Limiting Step ◽  
Fibril Morphology ◽  
Rate Limiting

The universally abundant polyphosphate (polyP) accelerates fibril formation of disease-related amyloids and protects against amyloid cytotoxicity. To gain insights into the mechanism(s) by which polyP exerts these effects, we focused on α-synuclein, a well-studied amyloid protein, which constitutes the major component of Lewy bodies found in Parkinson’s disease. Here, we demonstrate that polyP is unable to accelerate the rate-limiting step of α-synuclein fibril formation but effectively nucleates fibril assembly once α-synuclein oligomers are formed. Binding of polyP to α-synuclein either during fibril formation or upon fibril maturation substantially alters fibril morphology and effectively reduces the ability of α-synuclein fibrils to interact with cell membranes. The effect of polyP appears to be α-synuclein fibril specific and successfully prevents the uptake of fibrils into neuronal cells. These results suggest that altering the polyP levels in the extracellular space might be a potential therapeutic strategy to prevent the spreading of the disease.

scholarly journals Mechanistic Insights into the Protective Roles of Polyphosphate Against Amyloid Cytotoxicity

2019 ◽  
Author(s):  
Justine Lempart ◽  
Eric Tse ◽  
James A. Lauer ◽  
Magdalena I Ivanova ◽  
Alexandra Sutter ◽  
...  
Keyword(s):  
Extracellular Space ◽  
Therapeutic Strategy ◽  
Neuronal Cells ◽  
Lewy Bodies ◽  
Fibril Formation ◽  
Amyloid Protein ◽  
Rate Limiting Step ◽  
Limiting Step ◽  
Fibril Morphology ◽  
Rate Limiting

ABSTRACTThe universally abundant polyphosphate (polyP) accelerates fibril formation of disease-related amyloids and protects against amyloid cytotoxicity. To gain insights into the mechanism(s) by which polyP exerts these effects, we focused on α-synuclein, a well-studied amyloid protein, which constitutes the major component of Lewy bodies found in Parkinson’s Disease. Here we demonstrate that polyP is unable to accelerate the rate-limiting step of α-synuclein fibril formation but effectively nucleates fibril assembly once α-synuclein oligomers are formed. Binding of polyP to α-synuclein either during fibril formation or upon fibril maturation substantially alters fibril morphology, and effectively reduces the ability of α-synuclein fibrils to interact with cell membranes. The effect of polyP appears to be α-synuclein fibril specific, and successfully prevents the uptake of fibrils into neuronal cells. These results suggest that altering the polyP levels in the extracellular space might be a potential therapeutic strategy to prevent the spreading of the disease.

scholarly journals Coupled Glucose Transport and Metabolism in Cultured Neuronal Cells: Determination of the Rate-Limiting Step

1995 ◽  
Vol 15 (5) ◽  
pp. 814-826 ◽  
Author(s):  
Richard R. Whitesell ◽  
Michael Ward ◽  
Anthony L. McCall ◽  
Daryl K. Granner ◽  
James M. May
Keyword(s):  
Glucose Transport ◽  
Glucose Utilization ◽  
Neuroblastoma Cell ◽  
Neuronal Cells ◽  
Neuronal Cell ◽  
Cell Types ◽  
Rate Limiting Step ◽  
Limiting Step ◽  
Rate Limiting ◽  
Intracellular Glucose

In brain and nerves the phosphorylation of glucose, rather than its transport, is generally considered the major rate-limiting step in metabolism. Since little is known regarding the kinetic coupling between these processes in neuronal tissues, we investigated the transport and phosphorylation of [2-3H]glucose in two neuronal cell models: a stable neuroblastoma cell line (NCB20), and a primary culture of isolated rat dorsal root ganglia cells. When transport and phosphorylation were measured in series, phosphorylation was the limiting step, because intracellular glucose concentrations were the same as those outside of cells, and because the apparent Km for glucose utilization was lower than expected for the transport step. However, the apparent Km was still severalfold higher than the Km of hexokinase I. When [2-3H]glucose efflux and phosphorylation were measured from the same intracellular glucose pool in a parallel assay, rates of glucose efflux were three- to-fivefold greater than rates of phosphorylation. With the parallel assay, we observed that activation of glucose utilization by the sodium channel blocker veratridine caused a selective increase in glucose phosphorylation and was without effect on glucose transport. In contrast to results with glucose, both cell types accumulated 2-deoxy-d-[14C]glucose to concentrations severalfold greater than extracellular concentrations. We conclude from these studies that glucose utilization in neuronal cells is phosphorylation-limited, and that the coupling between transport and phosphorylation depends on the type of hexose used.

scholarly journals Dissociation from the Oligomeric State Is the Rate-limiting Step in Fibril Formation by κ-Casein

2008 ◽  
Vol 283 (14) ◽  
pp. 9012-9022 ◽  
Author(s):  
Heath Ecroyd ◽  
Tomas Koudelka ◽  
David C. Thorn ◽  
Danielle M. Williams ◽  
Glyn Devlin ◽  
...  
Keyword(s):  
Fibril Formation ◽  
Oligomeric State ◽  
Rate Limiting Step ◽  
Limiting Step ◽  
Rate Limiting

Ornithine Decarboxylase Activity in Cultured Endothelial Cells Stimulated by Serum, Thrombin and Serotonin

1978 ◽  
Vol 39 (02) ◽  
pp. 496-503 ◽  
Author(s):  
P A D’Amore ◽  
H B Hechtman ◽  
D Shepro
Keyword(s):  
Endothelial Cells ◽  
Ornithine Decarboxylase ◽  
Decarboxylase Activity ◽  
Aortic Endothelial Cells ◽  
Ornithine Decarboxylase Activity ◽  
Rate Limiting Step ◽  
Bovine Aortic Endothelial Cells ◽  
Limiting Step ◽  
Rate Limiting ◽  
Serum Serotonin

SummaryOrnithine decarboxylase (ODC) activity, the rate-limiting step in the synthesis of polyamines, can be demonstrated in cultured, bovine, aortic endothelial cells (EC). Serum, serotonin and thrombin produce a rise in ODC activity. The serotonin-induced ODC activity is significantly blocked by imipramine (10-5 M) or Lilly 11 0140 (10-6M). Preincubation of EC with these blockers together almost completely depresses the 5-HT-stimulated ODC activity. These observations suggest a manner by which platelets may maintain EC structural and metabolic soundness.

Dynamics of hepatic and peripheral insulin effects suggest common rate-limiting step in vivo

Diabetes ◽  
1993 ◽  
Vol 42 (2) ◽  
pp. 296-306 ◽  
Author(s):  
D. C. Bradley ◽  
R. A. Poulin ◽  
R. N. Bergman
Keyword(s):  
Rate Limiting Step ◽  
Limiting Step ◽  
Rate Limiting
Sign in / Sign up

Export Citation Format

Share Document